Abfero Pharmaceuticals

About:

Abfero Pharmaceuticals is a clinical stage pharmaceutical company that specializes in healthcare and medical industry.

Website: https://www.abferopharmaceuticals.com

Top Investors: DeepWork Capital

Description:

Abfero Pharmaceuticals is a clinical-stage pharmaceutical company that specializes in the healthcare and medical industry. The company focuses exclusively on iron as a therapeutic target, its mission is to develop novel therapies for the treatment of iron-overload conditions. It was founded in 2016 and headquartered in Lexington, Massachusetts.

Total Funding Amount:

$6.68M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2016-01-01

Founders:

Raymond J. Bergeron, Steven Burke, Thomas Neenan

Number of Employees:

11-50

Last Funding Date:

2021-03-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai